Skeletal muscle mitochondria as a target to prevent or treat type 2 diabetes mellitus

Nature Reviews Endocrinology

Volumn 12, Issue 11, 2016, Pages 633-645

  Hesselink, Matthijs K C ^a   Schrauwen Hinderling, Vera ^a   Schrauwen, Patrick ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYL COENZYME A; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; CARNITINE ACETYLTRANSFERASE; CRYPTOCHROME 2; DYNAMIN I; GLUCOSE TRANSPORTER 4; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; MITOCHONDRIAL DNA; MITOFUSIN 2; NICOTINAMIDE ADENINE DINUCLEOTIDE; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; REACTIVE OXYGEN METABOLITE; SIRTUIN; SIRTUIN 1; TRANSCRIPTION FACTOR ARNTL; TRANSCRIPTION FACTOR CLOCK; UNCOUPLING PROTEIN 1; CARNITINE;

CALORIC RESTRICTION; CIRCADIAN RHYTHM; COLD EXPOSURE; DISEASE ASSOCIATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ELECTRON TRANSPORT; ENVIRONMENTAL TEMPERATURE; EXERCISE; GLUCOSE HOMEOSTASIS; HEAT STRESS; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; METABOLIC REGULATION; MITOCHONDRIAL RESPIRATION; MUSCLE MITOCHONDRION; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OXIDATIVE PHOSPHORYLATION UNCOUPLING; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SKELETAL MUSCLE; SLEEP; CRYOTHERAPY; DIABETES MELLITUS, TYPE 2; DIET THERAPY; DIETARY SUPPLEMENT; KINESIOTHERAPY; METABOLISM; PATHOPHYSIOLOGY; TEMPERATURE;

CALORIC RESTRICTION; CARNITINE; CIRCADIAN RHYTHM; CRYOTHERAPY; DIABETES MELLITUS, TYPE 2; DIET THERAPY; DIETARY SUPPLEMENTS; EXERCISE; EXERCISE THERAPY; HUMANS; INSULIN RESISTANCE; MITOCHONDRIA, MUSCLE; MUSCLE, SKELETAL; OBESITY; SLEEP; TEMPERATURE;

EID: 84979294074     PISSN: 17595029     EISSN: 17595037     Source Type: Journal    
DOI: 10.1038/nrendo.2016.104     Document Type: Review

References (176)

1. Navarro, A. & Boveris, A. The mitochondrial energy transduction system and the aging process. Am. J. Physiol. Cell Physiol. 292, C670-C686 (2007).
2. Shigenaga, M. K., Hagen, T. M. & Ames, B. N. Oxidative damage and mitochondrial decay in aging. Proc. Natl Acad. Sci. USA 91, 10771-10778 (1994).
3. Cortopassi, G. A. & Wong, A. Mitochondria in organismal aging and degeneration. Biochim. Biophys. Acta 1410, 183-193 (1999).
4. Carter, H., Chen, C. & Hood, D. Mitochondria, muscle health, and exercise with advancing age. Physiology 30, 208-223 (2015).
5. Hood, D., Uguccioni, G., Vainshtein, A. & D?souza, D. Mechanisms of exercise-induced mitochondrial biogenesis in skeletal muscle: implications for health and disease. Compr. Physiol. 1, 1119-1134 (2011).
6. Shulman, G. I. et al. Quantitation of muscle glycogen synthesis in normal subjects and subjects with noninsulin- dependent diabetes by 13C nuclear magnetic resonance spectroscopy. N. Engl. J. Med. 322, 223-228 (1990).
7. Unger, R. H. & Orci, L. Diseases of liporegulation: new perspective on obesity and related disorders. FASEB J. 15, 312-321 (2001).
8. Kelley, D. E., He, J., Menshikova, E. V. & Ritov, V. B. Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes 51, 2944-2950 (2002).
9. Navarro, A. & Boveris, A. The mitochondrial energy transduction system and the aging process. Am. J. Physiol. Cell Physiol. 292, C670-C686 (2007).
10. Shigenaga, M. K., Hagen, T. M. & Ames, B. N. Oxidative damage and mitochondrial decay in aging. Proc. Natl Acad. Sci. USA 91, 10771-10778 (1994).
11. Cortopassi, G. A. & Wong, A. Mitochondria in organismal aging and degeneration. Biochim. Biophys. Acta 1410, 183-193 (1999).
12. Carter, H., Chen, C. & Hood, D. Mitochondria, muscle health, and exercise with advancing age. Physiology 30, 208-223 (2015).
13. Hood, D., Uguccioni, G., Vainshtein, A. & D?souza, D. Mechanisms of exercise-induced mitochondrial biogenesis in skeletal muscle: implications for health and disease. Compr. Physiol. 1, 1119-1134 (2011).
14. Shulman, G. I. et al. Quantitation of muscle glycogen synthesis in normal subjects and subjects with noninsulin- dependent diabetes by 13C nuclear magnetic resonance spectroscopy. N. Engl. J. Med. 322, 223-228 (1990).
15. Unger, R. H. & Orci, L. Diseases of liporegulation: new perspective on obesity and related disorders. FASEB J. 15, 312-321 (2001).
16. Kelley, D. E., He, J., Menshikova, E. V. & Ritov, V. B. Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes 51, 2944-2950 (2002).
17. Navarro, A. & Boveris, A. The mitochondrial energy transduction system and the aging process. Am. J. Physiol. Cell Physiol. 292, C670-C686 (2007).
18. Shigenaga, M. K., Hagen, T. M. & Ames, B. N. Oxidative damage and mitochondrial decay in aging. Proc. Natl Acad. Sci. USA 91, 10771-10778 (1994).
19. Cortopassi, G. A. & Wong, A. Mitochondria in organismal aging and degeneration. Biochim. Biophys. Acta 1410, 183-193 (1999).
20. Carter, H., Chen, C. & Hood, D. Mitochondria, muscle health, and exercise with advancing age. Physiology 30, 208-223 (2015).
21. Hood, D., Uguccioni, G., Vainshtein, A. & D?souza, D. Mechanisms of exercise-induced mitochondrial biogenesis in skeletal muscle: implications for health and disease. Compr. Physiol. 1, 1119-1134 (2011).
22. Shulman, G. I. et al. Quantitation of muscle glycogen synthesis in normal subjects and subjects with noninsulin- dependent diabetes by 13C nuclear magnetic resonance spectroscopy. N. Engl. J. Med. 322, 223-228 (1990).
23. Unger, R. H. & Orci, L. Diseases of liporegulation: new perspective on obesity and related disorders. FASEB J. 15, 312-321 (2001).
24. Kelley, D. E., He, J., Menshikova, E. V. & Ritov, V. B. Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes 51, 2944-2950 (2002).
25. Ritov, V. B. et al. Deficiency of subsarcolemmal mitochondria in obesity and type 2 diabetes. Diabetes 54, 8-14 (2005).
26. Mootha, V. K. et al. PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet. 34, 267-273 (2003).
27. Patti, M. E. et al. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1. Proc. Natl Acad. Sci. USA 100, 8466-8471 (2003).
28. Petersen, K. F. et al. Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science 300, 1140-1142 (2003).
29. Petersen, K. F., Dufour, S., Befroy, D., Garcia, R. & Shulman, G. I. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N. Engl. J. Med. 350, 664-671 (2004).
30. Kemp, G. & Brindle, K. What do magnetic resonancebased measurements of Pi→ATP flux tell us about skeletal muscle metabolism? Diabetes 61, 1927-1934 (2012).
31. Schrauwen-Hinderling, V. B. et al. Impaired in vivo mitochondrial function but similar intramyocellular lipid content in patients with type 2 diabetes mellitus and BMI-matched control subjects. Diabetologia 50, 113-120 (2007).
32. Phielix, E. et al. Lower intrinsic ADP-stimulated mitochondrial respiration underlies in vivo mitochondrial dysfunction in muscle of male type 2 diabetic patients. Diabetes 57, 2943-2949 (2008).
33. Hancock, C. R. et al. High-fat diets cause insulin resistance despite an increase in muscle mitochondria. Proc. Natl Acad. Sci. USA 105, 7815-7820 (2008).
34. Turner, N. et al. Excess lipid availability increases mitochondrial fatty acid oxidative capacity in muscle: evidence against a role for reduced fatty acid oxidation in lipid-induced insulin resistance in rodents. Diabetes 56, 2085-2092 (2007).
35. Pospisilik, J. A. et al. Targeted deletion of AIF decreases mitochondrial oxidative phosphorylation and protects from obesity and diabetes. Cell 131, 476-491 (2007).
36. Schiff, M. et al. Mitochondria and diabetes mellitus: untangling a conflictive relationship? J. Inherit. Metab. Dis. 32, 684-698 (2009).
37. Dumas, J., Simard, G., Flamment, M., Ducluzeau, P. & Ritz, P. Is skeletal muscle mitochondrial dysfunction a cause or an indirect consequence of insulin resistance in humans? Diabetes Metab. 35, 159-167 (2009).
38. Joseph, A. & Hood, D. Relationships between exercise, mitochondrial biogenesis and type 2 diabetes. Med. Sport Sci. 60, 48-61 (2014).
39. Toledo, F. & Goodpaster, B. The role of weight loss and exercise in correcting skeletal muscle mitochondrial abnormalities in obesity, diabetes and aging. Mol. Cell. Endocrinol. 379, 30-34 (2013).
40. Brunmair, B. et al. Thiazolidinediones, like metformin, inhibit respiratory complex I: a common mechanism contributing to their antidiabetic actions? Diabetes 53, 1052-1059 (2004).
41. Madiraju, A. K. et al. Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase. Nature 510, 542-546 (2014).
42. Matsuzaki, S. & Humphries, K. M. Selective inhibition of deactivated mitochondrial complex I by biguanides. Biochemistry 54, 2011-2021 (2015).
43. Satapati, S. et al. Mitochondrial metabolism mediates oxidative stress and inflammation in fatty liver. J. Clin. Invest. 125, 4447-4462 (2015).
44. Romanello, V. & Sandri, M. Mitochondrial quality control and muscle mass maintenance. Front. Physiol. 6, 422 (2016).
45. Thomas, R. & Gustafsson, A. Mitochondrial autophagy. Circ. J. 77, 2449-2454 (2013).
46. Jung, H. S. & Lee, M. S. Role of autophagy in diabetes and mitochondria. Ann. NY Acad. Sci. 1201, 79-83 (2010).
47. Randle, P., Garland, P., Hales, C. & Newsholme, E. The glucose fatty-acid cycle its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 281, 785-789 (1963).
48. Storlien, L., Oakes, N. & Kelley, D. Metabolic flexibility. Proc. Nutr. Soc. 63, 363-368 (2004).
49. Kelley, D. E. & Mandarino, L. J. Fuel selection in human skeletal muscle in insulin resistance: a reexamination. Diabetes 49, 677-683 (2000).
50. Mihalik, S. J. et al. Increased levels of plasma acylcarnitines in obesity and type 2 diabetes and identification of a marker of glucolipotoxicity. Obesity (Silver Spring) 18, 1695-1700 (2010).
51. Seiler, S. E. et al. Obesity and lipid stress inhibit carnitine acetyltransferase activity. J. Lipid Res. 55, 635-644 (2014).
52. Lindeboom, L. et al. Long-echo time MR spectroscopy for skeletal muscle acetylcarnitine detection. J. Clin. Invest. 124, 4915-4925 (2014).
53. Song, F. et al. Oxidative stress, antioxidant status and DNA damage in patients with impaired glucose regulation and newly diagnosed type 2 diabetes. Clin. Sci. (Lond.) 112, 599-606 (2007).
54. Anderson, E. J. et al. Mitochondrial H2O2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans. J. Clin. Invest. 119, 573-581 (2009).
55. Amara, C. E. et al. Mild mitochondrial uncoupling impacts cellular aging in human muscles in vivo. Proc. Natl Acad. Sci. USA 104, 1057-1062 (2007).
56. Diehl, A. M. & Hoek, J. B. Mitochondrial uncoupling: role of uncoupling protein anion carriers and relationship to thermogenesis and weight control ?the benefits of losing control?. J. Bioenerg. Biomembr. 31, 493-506 (1999).
57. Wallin, I. E. The mitochondria problem. Am. Naturalist 57, 255-261 (1923).
58. Schatz, G., Haslbrunner, E. & Tuppy, H. Deoxyribonucleic acid associated with yeast mitochondria. Biochem. Biophys. Res. Commun. 15, 127-132 (1964).
59. Lee, C., Yen, K. & Cohen, P. Humanin: a harbinger of mitochondrial-derived peptides? Trends Endocrinol. Metab. 24, 222-228 (2013).
60. Lee, C. et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metab. 21, 443-454 (2015).
61. Mottis, A., Jovaisaite, V. & Auwerx, J. The mitochondrial unfolded protein response in mammalian physiology. Mamm. Genome 25, 424-433 (2014).
62. Ljubicic, V. et al. Transcriptional and posttranscriptional regulation of mitochondrial biogenesis in skeletal muscle: effects of exercise and aging.. Biochim. Biophys. Acta 1800, 223-234 (2010).
63. Lin, J. et al. Transcriptional co-activator PGC-1α drives the formation of slow-twitch muscle fibres. Nature 418, 797-801 (2002).
64. Hoeks, J. et al. Enhanced lipid-but not carbohydratesupported mitochondrial respiration in skeletal muscle of PGC-1α overexpressing mice. J. Cell. Physiol. 227, 1026-1033 (2012).
65. Choi, C. S. et al. Paradoxical effects of increased expression of PGC-1α on muscle mitochondrial function and insulin-stimulated muscle glucose metabolism. Proc. Natl Acad. Sci. USA 105, 19926-19931 (2008).
66. Summermatter, S. et al. PGC-1α improves glucose homeostasis in skeletal muscle in an activitydependent manner. Diabetes 62, 85-95 (2013).
67. Koves, T. R. et al. PPARγ coactivator-1α contributes to exercise-induced regulation of intramuscular lipid droplet programming in mice and humans. J. Lipid Res. 54, 522-534 (2013).
68. Meex, R. C. et al. Restoration of muscle mitochondrial function and metabolic flexibility in type 2 diabetes by exercise training is paralleled by increased myocellular fat storage and improved insulin sensitivity. Diabetes 59, 572-579 (2010).
69. Mensink, M. et al. Improved skeletal muscle oxidative enzyme activity and restoration of PGC-1α and PPARβ/δ gene expression upon rosiglitazone treatment in obese patients with type 2 diabetes mellitus. Int. J. Obes. (Lond.) 31, 1302-1310 (2007).
70. Canto, C. & Auwerx, J. PGC-1α, SIRT1 and AMPK, an energy sensing network that controls energy expenditure. Curr. Opin. Lipidol. 20, 98-105 (2009).
71. Zorzano, A., Hernandez-Alvarez, M. I., Palacin, M. & Mingrone, G. Alterations in the mitochondrial regulatory pathways constituted by the nuclear co-factors PGC-1α or PGC-1β and mitofusin 2 in skeletal muscle in type 2 diabetes. Biochim. Biophys. Acta 1797, 1028-1033 (2010).
72. Glancy, B. et al. Mitochondrial reticulum for cellular energy distribution in muscle. Nature 523, 617-620 (2015).
73. Westermann, B. Mitochondrial fusion and fission in cell life and death. Nat. Rev. Mol. Cell Biol. 11, 872-884 (2010).
74. Cipolat, S., Martins de Brito, O., Dal Zilio, B. & Scorrano, L. OPA1 requires mitofusin 1 to promote mitochondrial fusion. Proc. Natl Acad. Sci. USA 101, 15927-15932 (2004).
75. Herlan, M., Bornhovd, C., Hell, K., Neupert, W. & Reichert, A. S. Alternative topogenesis of Mgm1 and mitochondrial morphology depend on ATP and a functional import motor. J. Cell Biol. 165, 167-173 (2004).
76. Tondera, D. et al. SLP-2 is required for stress-induced mitochondrial hyperfusion. EMBO J. 28, 1589-1600 (2009).
77. Patten, D. A. et al. OPA1-dependent cristae modulation is essential for cellular adaptation to metabolic demand. EMBO J. 33, 2676-2691 (2014).
78. Liesa, M. & Shirihai, O. S. Mitochondrial dynamics in the regulation of nutrient utilization and energy expenditure. Cell Metab. 17, 491-506 (2013).
79. Lee, Y. J., Jeong, S. Y., Karbowski, M., Smith, C. L. & Youle, R. J. Roles of the mammalian mitochondrial fission and fusion mediators Fis1, Drp1, and Opa1 in apoptosis. Mol. Biol. Cell 15, 5001-5011 (2004).
80. Wikstrom, J. D. et al. Hormone-induced mitochondrial fission is utilized by brown adipocytes as an amplification pathway for energy expenditure. EMBO J. 33, 418-436 (2014).
81. Poehlman, E. T. & Horton, E. S. Regulation of energy expenditure in aging humans. Annu. Rev. Nutr. 10, 255-275 (1990).
82. Schrauwen, P., Xia, J., Bogardus, C., Pratley, R. E. & Ravussin, E. Skeletal muscle uncoupling protein 3 expression is a determinant of energy expenditure in Pima Indians. Diabetes 48, 146-149 (1999).
83. Twig, G. et al. Fission and selective fusion govern mitochondrial segregation and elimination by autophagy. EMBO J. 27, 433-446 (2008).
84. Sebastian, D. et al. Mitofusin 2 (Mfn2) links mitochondrial and endoplasmic reticulum function with insulin signaling and is essential for normal glucose homeostasis. Proc. Natl Acad. Sci. USA 109, 5523-5528 (2012).
85. Pich, S. et al. The Charcot-Marie-Tooth type 2A gene product, Mfn2, up-regulates fuel oxidation through expression of OXPHOS system. Hum. Mol. Genet. 14, 1405-1415 (2005).
86. Zuchner, S. et al. Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A. Nat. Genet. 36, 449-451 (2004).
87. Bach, D. et al. Expression of Mfn2, the Charcot- Marie-Tooth neuropathy type 2A gene, in human skeletal muscle. Diabetes 54, 2685-2693 (2005).
88. Jheng, H. F. et al. Mitochondrial fission contributes to mitochondrial dysfunction and insulin resistance in skeletal muscle. Mol. Cell. Biol. 32, 309-319 (2012).
89. Watanabe, T. et al. Roles of mitochondrial fragmentation and reactive oxygen species in mitochondrial dysfunction and myocardial insulin resistance. Exp. Cell Res. 323, 314-325 (2014).
90. Waterham, H. R. et al. A lethal defect of mitochondrial and peroxisomal fission. N. Engl. J. Med. 356, 1736-1741 (2007).
91. Wallberg-Henriksson, H. et al. Increased peripheral insulin sensitivity and muscle mitochondrial enzymes but unchanged blood glucose control in type I diabetics after physical training. Diabetes 31, 1044-1050 (1982).
92. James, D. E., Lederman, L. & Pilch, P. F. Purification of insulin-dependent exocytic vesicles containing the glucose transporter. J. Biol. Chem. 262, 11817-11824 (1987).
93. Menshikova, E. V. et al. Effects of weight loss and physical activity on skeletal muscle mitochondrial function in obesity. Am. J. Physiol. Endocrinol. Metab. 288, E818-E825 (2005).
94. Short, K. R. et al. Impact of aerobic exercise training on age-related changes in insulin sensitivity and muscle oxidative capacity. Diabetes 52, 1888-1896 (2003).
95. Toledo, F. G. et al. Effects of physical activity and weight loss on skeletal muscle mitochondria and relationship with glucose control in type 2 diabetes. Diabetes 56, 2142-2147 (2007).
96. Bajpeyi, S. et al. Skeletal muscle mitochondrial capacity and insulin resistance in type 2 diabetes. J. Clin. Endocrinol. Metab. 96, 1160-1168 (2011).
97. Hutchison, S. K. et al. Effect of exercise training on insulin sensitivity, mitochondria and computed tomography muscle attenuation in overweight women with and without polycystic ovary syndrome. Diabetologia 55, 1424-1434 (2012).
98. Hey-Mogensen, M. et al. Effect of physical training on mitochondrial respiration and reactive oxygen species release in skeletal muscle in patients with obesity and type 2 diabetes. Diabetologia 53, 1976-1985 (2010).
99. Hood, M. S., Little, J. P., Tarnopolsky, M. A., Myslik, F. & Gibala, M. J. Low-volume interval training improves muscle oxidative capacity in sedentary adults. Med. Sci. Sports Exerc. 43, 1849-1856 (2011).
100. Irving, B. A., Short, K. R., Nair, K. S. & Stump, C. S. Nine days of intensive exercise training improves mitochondrial function but not insulin action in adult offspring of mothers with type 2 diabetes. J. Clin. Endocrinol. Metab. 96, E1137-E1141 (2011).
101. Coen, P. M. et al. Exercise and weight loss improve muscle mitochondrial respiration, lipid partitioning, and insulin sensitivity after gastric bypass surgery. Diabetes 64, 3737-3750 (2015).
102. Phielix, E., Meex, R., Moonen-Kornips, E., Hesselink, M. K. & Schrauwen, P. Exercise training increases mitochondrial content and ex vivo mitochondrial function similarly in patients with type 2 diabetes and in control individuals. Diabetologia 53, 1714-1721 (2010).
103. Pagel-Langenickel, I. et al. A discordance in rosiglitazone mediated insulin sensitization and skeletal muscle mitochondrial content/activity in Type 2 diabetes mellitus. Am. J. Physiol. Heart Circ. Physiol. 293, H2659-H2666 (2007).
104. Malin, S. K. et al. Insulin sensitivity and metabolic flexibility following exercise training among different obese insulin-resistant phenotypes. Am. J. Physiol. Endocrinol. Metab. 305, E1292-E1298 (2013).
105. Bergouignan, A. et al. Effect of contrasted levels of habitual physical activity on metabolic flexibility. J. Appl. Physiol. (1985) 114, 371-379 (2013).
106. den Hoed, M., Hesselink, M. K., van Kranenburg, G. P. & Westerterp, K. R. Habitual physical activity in daily life correlates positively with markers for mitochondrial capacity. J. Appl. Physiol. (1985) 105, 561-568 (2008).
107. Karolkiewicz, J. et al. Response of oxidative stress markers and antioxidant parameters to an 8-week aerobic physical activity program in healthy, postmenopausal women. Arch. Gerontol. Geriatr. 49, e67-e71 (2009).
108. Konopka, A. R. et al. Defects in mitochondrial efficiency and H2O2 emissions in obese women are restored to a lean phenotype with aerobic exercise training. Diabetes 64, 2104-2115 (2015).
109. Ludzki, A. et al. Rapid repression of ADP transport by palmitoyl-CoA is attenuated by exercise training in humans: a potential mechanism to decrease oxidative stress and improve skeletal muscle insulin signaling. Diabetes 64, 2769-2779 (2015).
110. Mielke, C. et al. Adenine nucleotide translocase is acetylated in vivo in human muscle: modeling predicts a decreased ADP affinity and altered control of oxidative phosphorylation. Biochemistry 53, 3817-3829 (2014).
111. Sparks, L. M. et al. Ant1-mediated fatty acid-induced uncoupling as a target for improving myocellular insulin sensitivity. Diabetologia 59, 1030-1039 (2016).
112. Befroy, D. E. et al. Increased substrate oxidation and mitochondrial uncoupling in skeletal muscle of endurance-trained individuals. Proc. Natl Acad. Sci. USA 105, 16701-16706 (2008).
113. Ding, H. et al. Response of mitochondrial fusion and fission protein gene expression to exercise in rat skeletal muscle. Biochim. Biophys. Acta 1800, 250-256 (2010).
114. Cartoni, R. et al. Mitofusins 1/2 and ERRα expression are increased in human skeletal muscle after physical exercise. J. Physiol. 567, 349-358 (2005).
115. Garnier, A. et al. Coordinated changes in mitochondrial function and biogenesis in healthy and diseased human skeletal muscle. FASEB J. 19, 43-52 (2005).
116. Hernandez-Alvarez, M. I. et al. Subjects with earlyonset type 2 diabetes show defective activation of the skeletal muscle PGC-1α/mitofusin-2 regulatory pathway in response to physical activity. Diabetes Care 33, 645-651 (2010).
117. Fealy, C. E., Mulya, A., Lai, N. & Kirwan, J. P. Exercise training decreases activation of the mitochondrial fission protein dynamin-related protein-1 in insulinresistant human skeletal muscle. J. Appl. Physiol. (1985) 117, 239-245 (2014).
118. Finkel, T. The metabolic regulation of aging. Nat. Med. 21, 1416-1423 (2015).
119. Heilbronn, L. K. et al. Effect of 6-month calorie restriction on biomarkers of longevity, metabolic adaptation, and oxidative stress in overweight individuals: a randomized controlled trial. JAMA 295, 1539-1548 (2006).
120. Civitarese, A. E. et al. Calorie restriction increases muscle mitochondrial biogenesis in healthy humans. PLoS Med. 4, e76 (2007).
121. Guarente, L. Mitochondria- a nexus for aging, calorie restriction, and sirtuins? Cell 132, 171-176 (2008).
122. Sun, Q. et al. Overexpression of visfatin/PBEF/Nampt alters whole-body insulin sensitivity and lipid profile in rats. Ann. Med. 41, 311-320 (2009).
123. Yoshino, J., Mills, K. F., Yoon, M. J. & Imai, S. Nicotinamide mononucleotide, a key NAD+ intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice. Cell Metab. 14, 528-536 (2011).
124. Baur, J. A. et al. Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444, 337-342 (2006).
125. Milne, J. C. et al. Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes. Nature 450, 712-716 (2007).
126. Rutanen, J. et al. SIRT1 mRNA expression may be associated with energy expenditure and insulin sensitivity. Diabetes 59, 829-835 (2010).
127. Baksi, A. et al. A phase II, randomized, placebocontrolled, double-blind, multi-dose study of SRT2104, a SIRT1 activator, in subjects with type 2 diabetes. Br. J. Clin. Pharmacol. 78, 69-77 (2014).
128. Howitz, K. T. et al. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 425, 191-196 (2003).
129. de Ligt, M., Timmers, S. & Schrauwen, P. Resveratrol and obesity: can resveratrol relieve metabolic disturbances? Biochim. Biophys. Acta 1852, 1137-1144 (2015).
130. Timmers, S. et al. Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans. Cell Metab. 14, 612-622 (2011).
131. Timmers, S., Hesselink, M. K. & Schrauwen, P. Therapeutic potential of resveratrol in obesity and type 2 diabetes: new avenues for health benefits? Ann. NY Acad. Sci. 1290, 83-89 (2013).
132. Canto, C. et al. The NAD+ precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat diet-induced obesity. Cell Metab. 15, 838-847 (2012).
133. Gariani, K. et al. Eliciting the mitochondrial unfolded protein response via NAD repletion reverses fatty liver disease. Hepatology 63, 1190-1204 (2016).
134. Traba, J. et al. Fasting and refeeding differentially regulate NLRP3 inflammasome activation in human subjects. J. Clin. Invest. 125, 4592-4600 (2015).
135. van de Weijer, T. et al. Evidence for a direct effect of the NAD+ precursor acipimox on muscle mitochondrial function in humans. Diabetes 64, 1193-1201 (2015).
136. Pan, A., Schernhammer, E. S., Sun, Q. & Hu, F. B. Rotating night shift work and risk of type 2 diabetes: two prospective cohort studies in women. PLoS Med. 8, e1001141 (2011).
137. Suwazono, Y. et al. Shiftwork and impaired glucose metabolism: a 14-year cohort study on 7104 male workers. Chronobiol. Int. 26, 926-941 (2009).
138. Meisinger, C., Heier, M. & Loewel, H. Sleep disturbance as a predictor of type 2 diabetes mellitus in men and women from the general population. Diabetologia 48, 235-241 (2005).
139. Scheer, F. A., Hilton, M. F., Mantzoros, C. S. & Shea, S. A. Adverse metabolic and cardiovascular consequences of circadian misalignment. Proc. Natl Acad. Sci. USA 106, 4453-4458 (2009).
140. Karlsson, B., Knutsson, A. & Lindahl, B. Is there an association between shift work and having a metabolic syndrome? Results from a population based study of 27,485 people. Occup. Environ. Med. 58, 747-752 (2001).
141. Kalsbeek, A., la Fleur, S. & Fliers, E. Circadian control of glucose metabolism. Mol. Metab. 3, 372-383 (2014).
142. Yin, L., Wang, J., Klein, P. S. & Lazar, M. A. Nuclear receptor Rev-erbα is a critical lithium-sensitive component of the circadian clock. Science 311, 1002-1005 (2006).
143. Woldt, E. et al. Rev-erb-α modulates skeletal muscle oxidative capacity by regulating mitochondrial biogenesis and autophagy. Nat. Med. 19, 1039-1046 (2013).
144. Eckel-Mahan, K. L. et al. Reprogramming of the circadian clock by nutritional challenge. Cell 155, 1464-1478 (2013).
145. Peek, C. B. et al. Circadian clock NAD+ cycle drives mitochondrial oxidative metabolism in mice. Science 342, 1243417 (2013).
146. Jacobi, D. et al. Hepatic Bmal1 regulates rhythmic mitochondrial dynamics and promotes metabolic fitness. Cell Metab. 22, 709-720 (2015).
147. Noland, R. C. et al. Carnitine insufficiency caused by aging and overnutrition compromises mitochondrial performance and metabolic control. J. Biol. Chem. 284, 22840-22852 (2009).
148. Ringseis, R., Keller, J. & Eder, K. Role of carnitine in the regulation of glucose homeostasis and insulin sensitivity: evidence from in vivo and in vitro studies with carnitine supplementation and carnitine deficiency. Eur. J. Nutr. 51, 1-18 (2012).
149. Randle, P. J., Garland, P. B., Hales, C. N. & Newsholme, E. A. The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1, 785-789 (1963).
150. Hirschey, M. D. et al. SIRT3 deficiency and mitochondrial protein hyperacetylation accelerate the development of the metabolic syndrome. Mol. Cell 44, 177-190 (2011).
151. Marton, O. et al. Aging and exercise affect the level of protein acetylation and SIRT1 activity in cerebellum of male rats. Biogerontology 11, 679-686 (2010).
152. Davies, M. J. et al. The acetyl group buffering action of carnitine acetyltransferase offsets macronutrientinduced lysine acetylation of mitochondrial proteins. Cell Rep. 14, 1-12 (2016).
153. van Marken Lichtenbelt, W. D. et al. Cold-activated brown adipose tissue in healthy men. N. Engl. J. Med. 360, 1500-1508 (2009).
154. Betz, M. J. & Enerback, S. Human brown adipose tissue: what we have learned so far. Diabetes 64, 2352-2360 (2015).
155. Kajimura, S., Spiegelman, B. M. & Seale, P. Brown and beige fat: physiological roles beyond heat generation. Cell Metab. 22, 546-559 (2015).
156. Shibata, H., Perusse, F., Vallerand, A. & Bukowiecki, L. J. Cold exposure reverses inhibitory effects of fasting on peripheral glucose uptake in rats. Am. J. Physiol. 257, R96-R101 (1989).
157. Stanford, K. I. et al. Brown adipose tissue regulates glucose homeostasis and insulin sensitivity. J. Clin. Invest. 123, 215-223 (2013).
158. Hanssen, M. J. et al. Short-term cold acclimation improves insulin sensitivity in patients with type 2 diabetes mellitus. Nat. Med. 21, 863-865 (2015).
159. Hanssen, M. J. et al. Short-term cold acclimation recruits brown adipose tissue in obese humans. Diabetes 65, 1179-1189 (2016).
160. Bal, N. C. et al. Sarcolipin is a newly identified regulator of muscle-based thermogenesis in mammals. Nat. Med. 18, 1575-1579 (2012).
161. Maurya, S. K. et al. Sarcolipin is a key determinant of the basal metabolic rate, and its overexpression enhances energy expenditure and resistance against diet-induced obesity. J. Biol. Chem. 290, 10840-10849 (2015).
162. Milligan, L. P. & McBride, B. W. Energy costs of ion pumping by animal tissues. J. Nutr. 115, 1374-1382 (1985).
163. Chinet, A., Decrouy, A. & Even, P. C. Ca(2+)- dependent heat production under basal and nearbasal conditions in the mouse soleus muscle. J. Physiol. 455, 663-678 (1992).
164. Levine, J. A. et al. Interindividual variation in posture allocation: possible role in human obesity. Science 307, 584-586 (2005).
165. van Dijk, J. W. et al. Effect of moderate-intensity exercise versus activities of daily living on 24-hour blood glucose homeostasis in male patients with type 2 diabetes. Diabetes Care 36, 3448-3453 (2013).
166. Henson, J. et al. Breaking up prolonged sitting with standing or walking attenuates the postprandial metabolic response in postmenopausal women: a randomized acute study. Diabetes Care 39, 130-138 (2016).
167. Hooper, P. L. Hot-tub therapy for type 2 diabetes mellitus. N. Engl. J. Med. 341, 924-925 (1999).
168. Bruce, C. R., Carey, A. L., Hawley, J. A. & Febbraio, M. A. Intramuscular heat shock protein 72 and heme oxygenase-1 mRNA are reduced in patients with type 2 diabetes: evidence that insulin resistance is associated with a disturbed antioxidant defense mechanism. Diabetes 52, 2338-2345 (2003).
169. Kurucz, I. et al. Decreased expression of heat shock protein 72 in skeletal muscle of patients with type 2 diabetes correlates with insulin resistance. Diabetes 51, 1102-1109 (2002).
170. Chung, J. et al. HSP72 protects against obesityinduced insulin resistance. Proc. Natl Acad. Sci. USA 105, 1739-1744 (2008).
171. Gupte, A. A., Bomhoff, G. L., Swerdlow, R. H. & Geiger, P. C. Heat treatment improves glucose tolerance and prevents skeletal muscle insulin resistance in rats fed a high-fat diet. Diabetes 58, 567-578 (2009).
172. Liu, C. T. & Brooks, G. A. Mild heat stress induces mitochondrial biogenesis in C2C12 myotubes. J. Appl. Physiol. (1985) 112, 354-361 (2012).
173. Henstridge, D. C., Whitham, M. & Febbraio, M. A. Chaperoning to the metabolic party: the emerging therapeutic role of heat-shock proteins in obesity and type 2 diabetes. Mol. Metab. 3, 781-793 (2014).
174. Literati-Nagy, B. et al. Improvement of insulin sensitivity by a novel drug, BGP-15, in insulinresistant patients: a proof of concept randomized double-blind clinical trial. Horm. Metab. Res. 41, 374-380 (2009).
175. Nabben, M. et al. The effect of UCP3 overexpression on mitochondrial ROS production in skeletal muscle of young versus aged mice. FEBS Lett. 582, 4147-4152 (2008).
176. Schrauwen, P. & Hesselink, M. K. Oxidative capacity, lipotoxicity, and mitochondrial damage in type 2 diabetes. Diabetes 53, 1412-1417 (2004).